Phase III Trial of 3-weekly vs. 5-weekly Schedule of S-1 Plus Cisplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer.
Phase of Trial: Phase III
Latest Information Update: 27 Jul 2015
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms SOS
- 27 Jul 2015 Results published in the Annals of Oncology.
- 13 Jan 2014 Status changed from active, no longer recruiting to completed; according to ClinicalTrials.gov record.
- 31 May 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.